Description
Chemically-defined, serum-free, protein-free medium validated for recombinant lentiviral vector production
n
-
- Supports high cell density suspension cultures of CTS™ Viral Production Cells (HEK293F-derived cells)
n
-
- Suitable for preclinical-, clinical-, and commercial-scale transient transfection and lentiviral production when used with the CTS™ LV-MAX™ Transfection Kit
n
-
- Undergoes stringent QC testing to help ensure it is appropriate for the manufacturing of cell and gene therapy applications.
n
-
- May be applicable for other recombinant viral vector production that uses a HEK293 medium
n
-
- Supports CTS™ Viral Production Cells to achieve densities of over 1×107 cells/mL with minimal cell clumping
n
-
- Enables high viral titers of up to 1×108 TU/mL (unconcentrated lentiviral vectors–GFP)
n
-
- Scalable protocol for 96-deep well blocks, flasks, and bioreactors
n
-
- Regulatory-compliant medium manufactured in conformity with cGMP for medical devices, 21 CFR, Part 820, and certified to the ISO 13485. Drug Master File and Regulatory Support File available upon request
n
-
- Formulated with GlutaMAX™-I reagent
n
-
- Ready to use, with no supplementation required
n
-
- Chemically-defined formulation results in high reproducibility and lot-to-lot reliability
n
-
- Contains no human or animal-origin components
n
-
- Not recommended for adherent cell cultures
n
-
- Formulation of this product is identical to research grade LV-MAX™ Production Medium, but CTS™ LV-MAX™ Production Medium is validated for clinical and commercial therapeutic applications
n